Regulatory Outlook 2026–2027 for MedTech, BioTech and Pharma
An overview of the key regulatory developments for 2026–2027, helping companies identify upcoming requirements early and prepare for them effectively.
Regulatory Outlook 2026–2027
Three Key Regulatory Areas in Focus
Between 2026 and 2027, regulatory requirements are evolving simultaneously at European, international and digital level. These three areas bring together the most important developments for medical devices, pharmaceuticals and life sciences and show which deadlines, market requirements and emerging compliance topics companies should assess now.
Explore the Key Areas
EU Developments
The PPWR, MDR and IVDR, the EU Machinery Regulation and new GMP requirements are changing product requirements, technical documentation, packaging and quality processes.
International Developments
The United States, United Kingdom, Canada, Australia and Switzerland are developing their regulatory frameworks in different directions. Market access, registration and UDI remain key priorities.
Digital Developments
Artificial intelligence, cybersecurity, health data and modern software assurance are changing regulatory practice and are increasingly becoming part of established quality processes.
EU Regulation 2026–2027
Key Regulatory Dates in the European Union
IVDR: Application and Written Agreement for Class B and Class A Sterile Devices
International Regulation 2026–2027
Key Regulatory Dates in International Markets
Switzerland: Transitional Period for swissdamed Registration Ends
Digital Regulation 2026–2027
Key Dates for AI, Cybersecurity and Digital Compliance
From Regulation to Implementation
What Companies Need to Implement Now
Between 2026 and 2027, new regulatory requirements are reshaping key quality, market access and digital processes. These include MDR/IVDR and EUDAMED, the PPWR and Machinery Regulation, international requirements relating to the FDA, UDI and market access, as well as the AI Act, Cyber Resilience Act and health data regulation. Companies should therefore assess at an early stage which processes, evidence and responsibilities need to be adapted.
Key Areas for Action
Three Regulatory Workstreams for 2026–2027
Implement MDR/IVDR, PPWR and the Machinery Regulation
Several implementation phases are converging in the EU: MDR and IVDR transitional provisions and agreements with Notified Bodies, the phased mandatory use of EUDAMED, new packaging requirements under the PPWR, and preparation for the Machinery Regulation from 2027. Relevant GMP and quality requirements must also be taken into account where applicable.
Prepare Separately for the FDA, UK and Other Target Markets
Requirements outside the EU are increasingly diverging. In the United States, key areas include the FDA QMSR, cybersecurity and UDI, while the United Kingdom is developing a new international reliance model. Canada, Australia and Switzerland are also changing registration, recognition and lifecycle requirements.
Operationalise the AI Act, Cybersecurity and Health Data Requirements
Digital regulation is increasingly becoming part of quality and product management. The AI Act requires structured classification of AI systems and appropriate governance. At the same time, the Cyber Resilience Act, software assurance requirements and the European Health Data Space are raising expectations for cybersecurity, validation, data quality and clear responsibilities.
MDR/IVDR, EUDAMED, PPWR, international market access rules, the AI Act and cybersecurity requirements partly affect the same processes, systems and evidence. Regulatory Affairs, Quality Management, Development, IT, Production and Market Access should therefore consolidate these changes into a shared regulatory action plan.
A gap analysis makes it clear which regulatory requirements are already fulfilled and where concrete action is still required across products, processes, evidence and responsibilities.
Grünewald Consulting
Turning Regulatory Requirements into Practical Implementation
We support medical device, pharmaceutical and life sciences companies in assessing specific regulatory impacts, adapting documentation and quality management systems, ensuring regulatory and audit readiness, and implementing the required measures on time.
Our Services
From Gap Analysis and Market Approval to Validation and Audit Readiness
Our support ranges from regulatory gap analyses and product classification to technical documentation, QMS adjustments and software validation, as well as preparation for audits, inspections and international market approvals.
Regulatory Compliance & Market Approval
We support you with MDR and IVDR requirements, product classification, technical documentation, clinical and regulatory evidence, EUDAMED and UDI processes, as well as approval strategies and post-market requirements.
Quality Management & Audit Readiness
We assess QMS structures against ISO 13485, MDR/IVDR, FDA QMSR and other relevant requirements, identify specific gaps and prepare processes, evidence and responsible teams for audits and inspections.
Risk Management
We support risk management in accordance with ISO 14971, risk analyses for products and processes, and the integration of risk management with development, cybersecurity, post-market surveillance and technical evidence.
Research & Development
We structure development processes around regulatory requirements and support Design Controls, Requirements Engineering, validation, change management and traceable technical documentation.
Production, Qualification & Validation
We support equipment, process and cleaning qualification, process validation and the validation of computerised systems, as well as transfer activities, deviation management and robust regulatory evidence.
Digital Compliance & Software
We support you with the AI Act, cybersecurity, software lifecycle processes, GAMP 5, Computer Software Assurance, data integrity and risk-based validation of digital and AI-enabled systems.
Market Access & Internationalisation
We assess regulatory requirements for the United States, United Kingdom, Canada, Australia, Switzerland and other target markets and develop practical approval, registration and market access strategies.
Strategy & Management
We translate regulatory changes into practical decision-making frameworks for management and specialist departments, including resource planning, responsibilities, implementation roadmaps and regulatory risk management.
Which Regulatory Changes Do You Need to Implement by 2027?
Whether MDR and IVDR transitional requirements, EUDAMED, FDA QMSR, international market approval, the AI Act, cybersecurity or validation: we assess the impact on your products and processes, identify regulatory gaps and develop a practical action plan with priorities, responsibilities and implementation deadlines.
Your Direct Contact
I am happy to assist you personally.